Investigation announced for Investors who lost money with shares of Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL)

An investigation was announced for investors of Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) shares over potential securities laws violations by Zentalis Pharmaceuticals, Inc. in connection with certain financial statements.

Investors who purchased shares of Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm focuses on whether certain statements by Zentalis Pharmaceuticals, Inc. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

New York based Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers.

On June 18, 2024, Zentalis Pharmaceuticals, Inc. informed the market that "the U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on the following studies of azenosertib: the Phase 1 ZN-c3-001 dose-escalation study in solid tumors, the Phase 2 ZN-c3-005 (DENALI) study in platinum-resistant ovarian cancer (PROC) and the Phase 2 ZN-c3-004 (TETON) study in uterine serous carcinoma (USC)."

Shares of Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) declined from $27.51 per share on September 01, 2023, to as low as $2.83 per share on August 14, 2024.

Those who purchased shares of Zentalis Pharmaceuticals, Inc. (NASDAQ: ZNTL) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.